Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release May 26 2021

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-may-26-2021-2

Cadila Healthcare Limited has informed the Exchange regarding a press release dated May 26, 2021, titled "Zydus and TLC sign agreement to market Liposomal Amphotericin B, a critical drug to treat Black Fungus or Mucormycosis in India".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases